News
Advertisement
Advertisement
Delivering the Drs. Henry and Frederick Sutro Memorial Lecture, David W. Parke II, MD, CEO of the American Academy of Ophthalmology, points out that patients and physicians can benefit from innovations in treatment. However, health policy and economics often can stand in the way of innovation.
Advertisement
The Glaucoma Symposium offers ophthalmology and optometry professionals an opportunity to sharpen their knowledge about glaucoma.
Advertisement
Key opinion leaders review approaches used to improve outcomes in patients with open-angle glaucoma.
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Ophthalmology pipeline watch: Key trial results and PDUFA dates for Q1 2026
2
Ocugen releases positive preliminary 12-month data from phase 2 ArMaDa trial
3
PRIMA retinal implant restores vision in patients with advanced GA
4
Ocugen publishes phase 1 GARDian1 gene therapy data for Stargardt disease
5